Computype, Inc. and Wheaton Industries have partnered to help biopharmaceutical companies improve standard laboratory processes such as sample tracking and inventory management through the use of pre-labeled 2D barcoded glass microtubes.
An international team of scientists using Diamond Light Source, the UK’s national synchrotron facility, has successfully solved the complex 3D structure of the human Histamine H1 receptor protein.
Adocia SAS, a biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced the launch of its second clinical trial for the development of HinsBet, a fast-acting human insulin.
Shire plc announced that a Food and Drug Administration advisory panel supported approval of FIRAZYR for the treatment of acute attacks of hereditary angioedema.
Apricus Biosciences Inc. said it is reconsidering its regulatory strategy for its foot fungus treatment MycoVa, indicating it may seek approval to market the drug for patients who don't have athlete's foot.
GenoLogics’s pre-configured version of its LIMS software for Illumina next-generation sequencing (NGS) systems and TruSeq Sample Prep Kits speeds implementation time for labs with Illumina systems and provides users with the flexibility to interface with other genomics systems. An application programming interface (API) allows users to extend the LIMS to accommodate future changes in the lab.
Pfizer Inc. said it filed for marketing approval of its drug candidate axitinib as a treatment for advanced renal cell carcinoma, the most common type of kidney cancer.
Gilead Sciences Inc. and Johnson & Johnson have agreed to collaborate on a pill that combines Johnson & Johnson's HIV drug Prezista with Gilead's drug candidate cobicistat, which is designed to make other anti-retroviral drugs more effective.
Two Fold Software Limited, has enhanced the interface design and user friendliness of the Run Manager software module of its Qualoupe LIMS solution to enable users to set up queues of samples to be processed through a specific laboratory instrument for a given method.
Expo Technologies and Umetrics Inc. developed Expo’s NovaMath 5.0, which can use models built in SIMCA- P+ by the SIMCA-QP tool.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and Alkermes, Inc. announced additional results from a Phase 2 study of an investigational, once-monthly injectable suspension formulation of exenatide that showed substantial improvements in glycemic control, including reductions in A1C and fasting plasma glucose, with modest weight loss.
Boehringer Ingelheim and Eli Lilly and Company announced results demonstrating linagliptin was as effective at lowering blood sugar as glimepiride, and with weight loss instead of weight gain, a lower incidence of investigator-defined hypoglycemia.
Amylin Pharmaceuticals, Inc. announced data from a new analysis characterizing the effects of Symlin (pramlintide acetate) injection in patients with type 1 diabetes who used insulin pumps during two completed clinical studies.
Bristol-Myers Squibb and AstraZeneca announced results from two 24-week Phase 3 clinical studies examining the investigational compound dapagliflozin at 5 mg or 10 mg (clinical trial dose) plus metformin extended-release (XR).
Results from a clinical trial presented at the American Diabetes Association 71st Scientific Sessions (ADA), suggests that nutritional management of diabetic neuropathy with L-methylfolate, methylcobalamin, and pyridoxal 5’-phosphate, a prescription medical food dispensed by prescription and commercially as Metanx, improves total symptoms and health related quality of life.